Kynurenine 3-monooxygenase (KMO) is a critical regulator of renal ischemia-reperfusion injury
Preprint
Abstract
SUMMARY: Acute kidney injury (AKI) following ischemia-reperfusion injury (IRI) has a high mortality and lacks specific therapies. Here, we report that mice lacking kynurenine 3-monooxygenase (KMO) activity ( Kmo null mice) are protected against AKI after renal IRI. This advances our previous work showing that KMO blockade protects against acute lung injury and AKI in experimental multiple organ failure caused by acute pancreatitis. We show that KMO is highly expressed in the kidney and exerts major metabolic control over the biologically-active kynurenine metabolites 3-hydroxykynurenine, kynurenic acid and downstream metabolites. In experimental AKI induced by unilateral kidney IRI, Kmo null mice had preserved renal function, reduced renal tubular cell injury, and fewer infiltrating neutrophils compared to wild-type ( Kmo wt ) control mice. Together, these data confirm that flux through KMO contributes to AKI after IRI, and supports the rationale for KMO inhibition as a therapeutic strategy to protect against AKI during critical illness.Keywords
All Related Versions
- Published version: Experimental & Molecular Medicine, 51 (2), 1.
This publication has 27 references indexed in Scilit:
- Kynurenines: Tryptophan’s metabolites in exercise, inflammation, and mental healthScience, 2017
- Loss of Kynurenine 3-Mono-oxygenase Causes ProteinuriaJournal of the American Society of Nephrology, 2016
- Targeted Deletion of Kynurenine 3-Monooxygenase in MiceJournal of Biological Chemistry, 2013
- Cellular pathophysiology of ischemic acute kidney injuryJournal of Clinical Investigation, 2011
- Kynurenine metabolism predicts cognitive function in patients following cardiac bypass and thoracic surgeryJournal of Neurochemistry, 2011
- Apoptosis and acute kidney injuryKidney International, 2011
- Statistical power analyses using G*Power 3.1: Tests for correlation and regression analysesBehavior Research Methods, 2009
- INCREASED PLASMA KYNURENINE VALUES AND KYNURENINE-TRYPTOPHAN RATIOS AFTER MAJOR TRAUMA ARE EARLY INDICATORS FOR THE DEVELOPMENT OF SEPSISShock, 2009
- Modulation of striatal quinolinate neurotoxicity by elevation of endogenous brain kynurenic acidBritish Journal of Pharmacology, 1998
- Kynurenic acid-induced protection of neurochemical and behavioural deficits produced by quinolinic acid injections into the nucleus basalis of ratsNeuroscience Letters, 1986